Department of Dermatology, The First Affiliated Hospital of Chongqing Medical University, No. 1, Youyi Road, Yuzhong District, Chongqing, 400016, China.
Eur J Clin Microbiol Infect Dis. 2024 May;43(5):1031-1036. doi: 10.1007/s10096-024-04800-3. Epub 2024 Mar 12.
We aimed to show the increasing incidence of invasive fungal infections due to Volvariella Volvacea in patients with immunosuppression.
We present a case of an invasive fungal infection caused by Volvariella volvacea, and summarize the clinical and pathological features based on this case and a review of the literature.
A total of seven patients with IFIs due to Volvariella Volvacea have been reported in the literature. The majority of cases have been obtained between 2019 and 2022. Including our case, they all had acquired immunosuppression. The lung and brain were the most commonly affected organs. All eight of these patients received antifungal therapy, but five still died one to seven months after occurrences of IFIs.
The incidence of invasive fungal infections due to Volvariella Volvacea is increasing in recent years. It mainly occurred in patients with immunosuppression, especially in patients with malignant hematological cancers, and increased mortality.
本研究旨在展示因伏革菌（Volvariella Volvacea）导致的免疫抑制患者侵袭性真菌感染发病率的增加。
我们报告了一例由伏革菌引起的侵袭性真菌感染，并基于此病例及文献复习总结了其临床和病理学特征。
文献中报道了 7 例因伏革菌导致的 IFI。大多数病例发生于 2019 年至 2022 年期间。包括我们的病例在内，所有患者均获得性免疫抑制。肺和脑是最常受累的器官。这 8 例患者均接受了抗真菌治疗，但仍有 5 例在发生 IFI 后 1 至 7 个月内死亡。
近年来，因伏革菌导致的侵袭性真菌感染发病率呈上升趋势。它主要发生在免疫抑制患者中，尤其是恶性血液系统癌症患者，死亡率增加。
Zotero 插件